SEMA3F and esophageal squamous cell carcinoma: The expression of semaphorin 3F (SEMA3F), a Nrp2 ligand that negatively regulates VEGFR3 activation, is downregulated in esophageal squamous cell carcinoma and is associated with increased VEGF-C and Nrp2 expression [116].